TABLE III.
List of OOC examples that are demonstrated in the vertical organization/order.
Organ model(s) | Used cells | Key studied parameter | Physiological parameters/readout | Reference |
---|---|---|---|---|
Gut-immune cells | Caco-2 and U937 | Caco-2 as a protection layer | TEER and inflammatory cytokines | 37 |
Skin-immune cells | HaCaT and U937 | HaCaT as a protection layer | TEER and inflammatory cytokines | 46 |
Gut-liver and skin-liver | Human primary cryopreserved hepatocytes and Kupffer cells, Caco2 and HT29 cells | Integration barrier tissue with parenchymal for pharmacokinetics | Permeability | 107 and 124 |
Blood–brain barrier | Human microvascular endothelial (BMVECs) from the iPS cell line IMR90-4 cells and primary human astrocytes | Differentiation under hypoxic conditions | Permeability and drug transport | 125 |
Lung airway | Primary airway epithelial hAECs and human lung microvascular endothelial cells | Lung inflammatory | Cytokine secretion | 126 |